Can tiny anchors prevent aortic aneurysm rupture?

NCT ID NCT07754318

Not yet recruiting Disease control Sponsor: Medtronic Cardiovascular Source: ClinicalTrials.gov ↗

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial is testing a device called the Heli-FX EndoAnchor system, which is used during minimally invasive repair of abdominal aortic aneurysms (a bulging, weakened area in the main artery). The device helps secure the stent graft in place, potentially preventing leaks or movement that could lead to serious complications. The study involves about 142 adults with aneurysms large enough to require treatment, and it will measure how well the device works and how safe it is over the first year.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Heli-FX EndoAnchor system (a device that anchors stent grafts in place during aneurysm repair)
What this could lead to: If it works, this device could help prevent dangerous leaks or movement of stent grafts, reducing the risk of aneurysm rupture and improving long-term outcomes for patients.
What could go wrong: This is a device study, and success depends on technical precision. Risks include major adverse events like heart attack, stroke, kidney failure, or device-related complications within 30 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AAA - ABDOMINAL AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal aortic aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AAA - ABDOMINAL AORTIC ANEURYSM

More trials for these conditions

Other studies related to the condition(s) this trial covers.